Enliven Therapeutics, Inc. (ELVN)

NASDAQ: ELVN · Real-Time Price · USD

58.82

+0.76 (1.31%)

At close: Aug 14, 2026, 4:00 PM EDT

58.94

+0.12 (0.21%)

After-hours: Aug 14, 2026, 7:34 PM EDT

Enliven Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	4,310	914	1,099	570	-	-
Market Cap Growth	264.06%	-16.86%	92.74%	-	-	-
Enterprise Value	3,416	437	808	307	-	-
Last Close Price	58.82	15.40	22.50	13.84	-	-
PB Ratio	4.81	1.99	3.55	2.32	-	-
P/TBV Ratio	4.81	1.99	3.55	2.32	-	-
Debt / Equity Ratio	0.00	0.00	-	0.00	0.01	0.00
Net Debt / Equity Ratio	-1.00	-1.01	-1.01	-1.03	-1.03	-1.03
Net Debt / EBITDA Ratio	7.19	3.87	3.01	3.09	1.94	4.46
Net Debt / FCF Ratio	13.33	6.56	4.28	4.12	2.29	5.69
Quick Ratio	63.21	27.92	19.70	9.78	7.78	19.13
Current Ratio	64.07	28.66	19.99	10.28	8.00	19.24
Return on Equity (ROE)	-15.31%	-26.95%	-32.04%	-44.90%	-41.90%	-20.94%
Return on Assets (ROA)	-11.00%	-18.65%	-21.87%	-28.94%	-24.66%	-12.67%
Return on Capital Employed (ROCE)	-13.90%	-26.00%	-33.70%	-33.40%	-52.70%	-23.00%
Earnings Yield	-2.46%	-11.35%	-8.10%	-12.55%	-	-
FCF Yield	-1.56%	-7.71%	-6.66%	-10.77%	-	-
Buyback Yield / Dilution	-26.53%	-20.38%	-32.43%	-1037.74%	60.02%	-56.70%

SEC Filings: 10-K · 10-Q